Dechert represented Valneva in the transaction. Valneva entered into a collaboration agreement with Pfizer to develop and commercialize Valneva’s Lyme disease vaccine candidate VLA15, which is…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now